Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/28/2025

Levofloxacin Dosing for Pneumonia and UTI

Pneumonia Dosing

  • The Infectious Diseases Society of America recommends levofloxacin 750 mg IV/PO once daily for 5-7 days for standard community-acquired pneumonia cases 1, 2
  • For Streptococcus pneumoniae, levofloxacin 750 mg IV/PO once daily is an alternative to first-line beta-lactams 1, 2
  • For Legionella species, levofloxacin 750 mg IV/PO once daily is the preferred agent 1, 3
  • For Mycoplasma pneumoniae, levofloxacin 750 mg IV/PO once daily for 7-14 days is an alternative to macrolides/doxycycline 2, 4
  • For Chlamydophila pneumoniae, levofloxacin 500-750 mg IV/PO once daily for 7-10 days is recommended 1, 2
  • For Haemophilus influenzae, levofloxacin 750 mg IV/PO once daily is recommended 1, 2

Urinary Tract Infection Dosing

  • No cited facts available for urinary tract infection dosing

Clinical Considerations

  • Response to treatment should be monitored by clinical parameters including temperature, respiratory and hemodynamic status, as recommended by the Clinical Microbiology and Infection society 5, 6
  • Switch from IV to oral therapy can be considered once clinical stability is achieved, as recommended by the Clinical Microbiology and Infection society 5, 6
  • For MRSA pneumonia, levofloxacin is not appropriate as monotherapy; vancomycin, teicoplanin, or linezolid should be used, as recommended by the Infectious Diseases Society of America 1, 2
  • Avoid levofloxacin monotherapy when Pseudomonas aeruginosa is suspected; combination therapy with an anti-pseudomonal β-lactam is recommended, as recommended by the Infectious Diseases Society of America 2